Prior guidance was $640M-$670M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics Reports Strong Revenue and Future Plans
- Corcept Therapeutics (CORT) Q3 Earnings Cheat Sheet
- Corcept Therapeutics price target raised to $80 from $45 at H.C. Wainwright
- Biotech Alert: Searches spiking for these stocks today
- Corcept Therapeutics price target raised to $76 from $65 at Truist